Biowaiver extension potential and IVIVC for BCS class II drugs by formulation design: Case study for cyclosporine self-microemulsifying formulation

Su Geun Yang

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Biowaiver extension potential and IVIVC for BCS class II drugs by formulation design: Case study for cyclosporine self-microemulsifying formulation'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science